Equity

Corporate Results

Vivimed Labs reports consolidated net loss of Rs 16.55 crore in the December 2025 quarter
(14-Mar-2026, 07:35 Hours IST)  
Net Loss of Vivimed Labs reported to Rs 16.55 crore in the quarter ended December 2025 as against net loss of Rs 5.98 crore during the previous quarter ended December 2024. Sales declined 56.20% to Rs 15.99 crore in the quarter ended December 2025 as against Rs 36.51 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales15.9936.51 -56
OPM %-68.292.88 -
PBDT-11.930.64 PL
PBT-16.55-5.98 -177
NP-16.55-5.98 -177

Powered by Capital Market - Live News

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)